ABBN.SW: $86.54 ▲ 0.44 (0.51%)ASML.AS: $1,582.20 ▲ 21.40 (1.37%)ENR.DE: $160.90 ▼ -1.60 (-0.98%)GLEN.L: $534.80 ▼ -0.50 (-0.09%)IFX.DE: $81.83 ▲ 1.27 (1.58%)NOKIA.HE: $12.39 ▲ 0.39 (3.25%)RIO.L: $7,261.00 ▼ -3.00 (-0.04%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

Janus Henderson Global Life Sciences Fund

JFNIX - NASDAQ

Identifiants & Marche

Ticker JFNIX
ISIN US4710234653
CIK 0000277751
Bourse NASDAQ
Devise USD

Classification

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web N/A

Description

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.